[Aceruloplasminemia, a rare condition not to be overlooked].

La Revue de médecine interne
H LobbesS Durupt

Abstract

Aceruloplasminemia is a rare iron-overload disease that should be better known by physicians. It is an autosomal recessive disorder due to mutations in ceruloplasmin gene causing systemic iron overload, including cerebral and liver parenchyma. The impairment of ferroxidase ceruloplasmin activity leads to intracellular iron retention leading aceruloplasminemia symptoms. Neurologic manifestations include cognitive impairment, ataxia, extrapyramidal syndrome, abnormal movements, and psychiatric-like syndromes. Physicians should search for aceruloplasminemia in several situations with high ferritin levels: microcytic anaemia, diabetes mellitus, neurological and psychiatric disorders. Diagnosis approach is based on the study of transferrin saturation and hepatic iron content evaluated by magnetic resonance imaging of the liver. Ceruloplasmin dosage is required in case of low transferrin saturation and high hepatic iron content and genetic testing is mandatory in case of serum ceruloplasmin defect. Neurological manifestations occur in the sixties decade and leads to disability. Iron chelators are widely used. Despite their efficacy on systemic and cerebral iron overload, iron chelators tolerance is poor. Early initiation of iron chel...Continue Reading

References

Jan 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·N TakahashiF W Putnam
Aug 17, 1999·Neurology·H MiyajimaT Kanno
Jun 5, 2002·Journal of Hepatology·Olivier LoréalPierre Brissot
Sep 28, 2002·The Journal of Biological Chemistry·Nathan E HellmanJonathan D Gitlin
Aug 15, 2006·Nature Chemical Biology·Sruti ShivaMark T Gladwin
Sep 22, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Suh Young Jeong, Samuel David
Jan 24, 2007·Acta Crystallographica. Section D, Biological Crystallography·Isabel BentoPeter F Lindley
Feb 20, 2007·Brain & Development·J KuhnT U Hoogenraad
Aug 1, 2008·European Neurology·Alisdair McNeillHiroaki Miyajima
Dec 1, 2006·Neuropsychiatric Disease and Treatment·Mark WalterfangDennis Velakoulis
May 1, 2010·Neurotoxicity Research·Glenda M BishopStephen R Robinson
Jun 10, 2010·Journal of Gastroenterology·Yoshibumi KanekoMasakazu Yamagishi
Jul 27, 2010·Biochimica Et Biophysica Acta·Satoshi KonoHiroaki Miyajima
Aug 6, 2010·Internal Medicine·Minemori WatanabeAtaru Okumura
May 20, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Ping-Lei PanHui-Fang Shang
Sep 9, 2011·Seminars in Liver Disease·Antonello PietrangeloElena Corradini
Nov 16, 2011·Archives of Ophthalmology·Natalie WolkowJoshua L Dunaief
Jan 27, 2012·The New England Journal of Medicine·Robert E Fleming, Prem Ponka
Oct 13, 2012·British Journal of Haematology·Clara Camaschella
Oct 19, 2013·Physiological Reviews·Tomas Ganz
Nov 12, 2013·International Review of Neurobiology·Satoshi Kono
Aug 30, 2014·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Hiroaki Miyajima
Jan 24, 2015·Journal of Movement Disorders·Penelope Hogarth
Feb 11, 2015·Diabetic Medicine : a Journal of the British Diabetic Association·L H P VroegindeweijJ G Langendonk
Sep 1, 2015·Parkinsonism & Related Disorders·Susanne A Schneider
Oct 7, 2015·Cell Metabolism·Hal DrakesmithTomas Ganz
Jan 8, 2016·Current Neurology and Neuroscience Reports·Susanne A Schneider
Apr 2, 2016·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Petr DusekJan Aaseth
Nov 7, 2016·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·L PoliBarbara Borroni
Dec 26, 2016·Parkinsonism & Related Disorders·Lena H P VroegindeweijAgnita J W Boon
Mar 6, 2018·Parkinsonism & Related Disorders·Sara PelucchiAlberto Piperno
Jul 7, 2018·Therapeutic Advances in Psychopharmacology·Tomasz LitwinJanusz K Rybakowski
Aug 18, 2018·Mutation Research. Reviews in Mutation Research·Pierre BrissotMarie-Bérengère Troadec
Jan 24, 2019·Journal of Inherited Metabolic Disease·Lena H P VroegindeweijJanneke G Langendonk
Apr 27, 2019·Frontiers in Neuroscience·Giacomo MarchiDomenico Girelli
Apr 3, 2020·International Journal of Molecular Sciences·Marc Vila CuencaMayka Sanchez
Apr 8, 2020·Translational Gastroenterology and Hepatology·Alberto PipernoRaffaella Mariani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.